Laparoscopic Power Morcellators Market
Report ID: SQMIG35A3456
Report ID: SQMIG35A3456
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3456 |
Region:
Global |
Published Date: May, 2026
Pages:
157
|Tables:
171
|Figures:
79
Global Laparoscopic Power Morcellators Market size was valued at USD 108.9 Million in 2024 and is poised to grow from USD 116.31 Million in 2025 to USD 196.87 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).
The laparoscopic power morcellators market consists of devices that are used in minimally invasive gynecologic surgeries to break down the uterine (myoma) tissue. The development of the morcellator allows for myomectomy and hysterectomy through small incisions while allowing for shorter hospitalizations and faster recovery. A key driver of laparoscopic power morcellators market growth is the global shift to minimally invasive surgical approaches, fueled by patient demand for lower morbidity and hospital incentives to reduce length of stay and cost.
The market continued to expand until patient safety concerns arose regarding the potential for the undiagnosed spread of lung cancers following the use of morcellators in surgical procedures in the mid-2010s. As a result of these concerns, regulatory advisories were issued, causing a reduction in surgery volume and a shift to developing safer containment methods and of improving clinician education and redesigning morcellators. Regulatory pressure had a significant impact on building confidence in morcellators within the surgical and medical communities as morcellators were redeveloped and improved methods of risk mitigation were developed.
As bags and ironing techniques have reduced the potential for the spread of cancer, most hospitals have returned to performing minimally invasive fibroid procedures, resulting in a resurgence in procedure volume and providing opportunity for manufacturing devices that can be used with robotic platforms. In emerging markets, where regulatory barriers are lower, rapid expansion of surgical capacity and an increase in demand for shorter hospital stays will continue to translate to growth in sales. Training programs and procurement strategies offer further expansion pathways, linking safety innovation directly to market expansion globally.
How is AI Improving Safety And Regulatory Compliance In The Laparoscopic Power Morcellators Market?
Artificial Intelligence (AI) is enhancing both safety and compliance through smart intraoperative decision-making, as well as greater oversight post-market, within the laparoscopic powered morcellators industry. The three primary areas where these improvements are represented are automated visual assessment of tissue; monitoring of containment integrity in real-time and documented procedures (whereby lessens probability of undocumented spreading of malignancies). The industry is transitioning away from complete avoidance toward a risk-managed, minimally invasive approach to healthcare due to the emergence of containment systems from manufacturers and analytic adoption from hospitals. Through use of AI powered devices, the integrity of the bag can be verified; device performance can be monitored; and audit-ready records can be generated for regulators and quality teams.
By creating combined device-and-data strategies, clinician confidence is being restored while matching evolving guidelines for safety. In April 2025, Ark Surgical received their 510(k) clearance from the FDA for The LapBox POWER Device, further demonstrating that there is market demand for containment solutions. Using containment devices in conjunction with an AI powered imaging and analytic systems will increase intraoperative safety, automate compliance reporting and speed up signal detection in the post-market for facilitating the broader adoption of care and efficiency within the profession.
Market snapshot - (2026-2033)
Global Market Size
USD 108.9 Million
Largest Segment
Reusable Laparoscopic Power Morcellators
Fastest Growth
Disposable Laparoscopic Power Morcellators
Growth Rate
6.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global laparoscopic power morcellators market is segmented by product type, component, application, usability, end user, distribution channel and region. Based on product type, the market is segmented into Reusable Laparoscopic Power Morcellators and Disposable Laparoscopic Power Morcellators. Based on component, the market is segmented into Morcellator Handpieces, Blades & Cutting Accessories, Tissue Containment Systems and Power Consoles & Control Units. Based on application, the market is segmented into Hysterectomy, Myomectomy, Nephrectomy and Other Laparoscopic Surgical Procedures. Based on usability, the market is segmented into Manual Power Morcellators and Electromechanical Power Morcellators. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs) and Specialty Gynecology Clinics. Based on distribution channel, the market is segmented into Direct Sales, Distributors & Dealers and Online Procurement. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per laparoscopic power morcellators market analysis, the tissue containment systems market dominates due to an increasing focus by clinicians on preventing specimen dissemination, where containment has become an expected safety feature in morcellation procedures. As well, the integration of tissue containment systems with current morcellators, regulatory support for the use of containment, and risk mitigation zeal by surgeons are also significant factors influencing procurement decisions by customers. Lastly, dependable tissue containment devices provide reduced liability for surgeons and create a wider acceptance of minimally invasive procedures that result in stable demand from hospitals. Hence, tissue containment has emerged at the heart of the market’s overall adoption.
As per laparoscopic power morcellators market forecast, blades and cutting accessories represent the fastest growing segment because of concentrated effort at innovation in blade design, blade coatings, and single-use sterile formats, resulting in greater cutting efficiency and fewer operating times. A growing surgeon preference for dependable/disposable consumables and supplier emphasis on providing repeated supplies increases aftermarket revenue for blade suppliers, resulting in morcellators being upgraded to be compatible with newer blades; thereby, establishing additional channels for product development and commercialization of newly developed morcellator products.
As per laparoscopic power morcellators market outlook, the major share of this market is attributed to hospitals, which manage a high volume of complex surgical procedures. Hospitals also typically possess large capital budgets to fund the purchase of new technologies, a formal process for purchasing systems, and an integrated operating room infrastructure that supports the acquisition of advanced morcellation systems. Training programs and risk management protocols within hospitals prioritize the use of morcellation devices that have a history of successful use with safety and containment measures, which helps to shape the vendor road maps within the hospitals' procurement priorities and service agreements with suppliers. As such, hospitals are able to provide manufacturers with a strong incentive to provide complete solutions to hospitals by driving the clinical adoption of new technologies and establishing the standards for technology used within the operating room.
On the other hand, the ambulatory surgery center (ASC) segment is experiencing the most rapid growth due to the fact that the trend toward minimally invasive outpatient care is driving a greater demand for compact, cost-effective morcellation solutions. ASCs prefer disposable and/or electrically powered morcellation devices that can be rapidly turned over and are therefore encouraging manufacturers to offer customized product bundles, training, and service packages that expand a manufacturer's reach and create new opportunities for adoption.
To get detailed segments analysis, Request a Free Sample Report
As per laparoscopic power morcellators market regional analysis, the global market is dominated by North America. This is primarily due to the following reasons a mature health care infrastructure, the concentration of specialized surgical centers, and the extensive use of minimally invasive gynecological surgeries. In addition, there is an abundance of clinical competence and established reimbursement paths to support the adoption of advanced morcellation technologies in North America. As renowned manufacturers of laparoscopic devices situated across the region, as well as partnerships between hospitals and industry for ongoing improvements to products and continuing education initiatives, continuous improvements are made in the availability of quality laparoscopy-powered morcellators. The rules and regulations set forth by various regulatory and professional organizations regarding the guidelines for safe use of medical devices will also enhance confidence in the market for these types of devices. The combination of high levels of clinician education, well-defined networks for the organization for training, and early adoption of new technologies creates an environment where the demand for these devices is maintained and also encourages additional investment for the development of devices and for the provision of services within the respective business sectors throughout North America.
In the USA, the laparoscopic power morcellators market has strong expertise in the area of clinical care, centres of excellence and availability of the product. An extensive level of clinician knowledge will facilitate the continuous inclusion of advanced morcellating devices for daily use in minimally invasive surgery. The relationship between the companies providing the morcellators and those performing the surgeries supports continuous improvement of the products, as well as training of both the surgeon and surgical assistants. Because concerns regarding patient safety are paramount, as well as the standardization of credentialing and institutional protocols, surgeons are confident in the continued use of high-quality morcellators in their surgeries.
The Canadian market for laparoscopic power morcellators is largely driven by the number of centres performing this type of procedure and their adoption of the technology varies from region to region. As a result, the adoption of morcellation will continue to be based on the safety of the morcellation process, standardization of various protocols and the completion of training programs. The use of collaborative purchasing will allow for both the continued availability of morcellators and the necessary education. Continued focus on quality improvement and interdisciplinary collaboration will create sufficient demand for morcellations to be included in the provision of minimally invasive gynecologic surgical services in Canada and assist in meeting national healthcare delivery goals.
As per laparoscopic power morcellators market regional outlook, Europe is experiencing rapid expansion in laparoscopic power morcellators market driven by a dynamic combination of clinical demand for minimally invasive gynecological solutions, proactive clinical networks, and increasing availability of advanced device options. Strong research and professional societies promote evidence based practice and harmonized procedural guidelines that support safe adoption across diverse healthcare systems. Strategic partnerships among manufacturers, hospitals, and training centers enable technology dissemination and hands on education. Reimbursement frameworks in many countries, growing surgical specialization, and focus on reducing patient recovery times further stimulate uptake, while regulatory oversight and post market learning encourage responsible implementation and continuous refinement of morcellation techniques. Collectively these factors create a favorable environment for innovation, localized product adaptation, and multi center clinical collaboration that accelerates safe use and adoption across the region.
Germany's Laparoscopic Power Morcellators Market benefits from: the level of surgical specialization; the number of tertiary facilities; and the clinical research activity to guide device selection and procedures. There is also a network of physicians and a number of national organizations to assist in promoting and developing guidelines and teaching physicians. Germany also has a significant number of device manufacturers and service providers, making morcellation technologies readily available through different healthcare delivery models. Patient safety and credentialing provide clinicians confidence and support Germany's designation as a leading regional entity.
In the United Kingdom, the Laparoscopic Power Morcellators Market is characterized by: a growing adoption of morcellators; increased spending on surgeon training; and hospital procurement programs that prefer minimally invasive technology. Professional organizations and national health initiatives have contributed to the development of standardized training and safety protocols, therefore enhancing clinical acceptance. In addition, joint pilot projects and collaborations between industry experts have accelerated the pace of technology evaluation and credentialing of clinicians. The focus on reducing patient recovery times and improving the patient experience continues to accelerate the integration of morcellation technology in many clinical settings.
In France , the laparoscopic power morcellators sector is characterized by careful adoption of technologies, increased clinician engagement, and a growing emphasis on practicing according to established guidelines . Clinical experiences from academic centers and specialized surgical teams will drive systemic adoption across hospitals. Patient safety, multidisciplinary decision making, and targeted training are examples of ways to enable the growth of morcellation use cautiously and appropriately. Manufacturing companies working with regional health care networks will increase access to morcellation devices and provide more tailored service models that match institutional capabilities and clinical priorities.
A combination of focused clinical capability development, expanding specialist surgical programs and increased collaboration with global manufacturers is driving Asia Pacific to increase its laparoscopic power morcellators market share. While regional centres of excellence are utilizing advanced morcellation technology, local distributors are providing education and service support to enable doctors to use the devices according to their specific clinical workflow. Increased focus on procedural safety and localized generation of evidence, along with targeted surgeon education, have all reduced the financial and clinical impediments to the adoption of these morcellators. Investments in training for minimally invasive surgery, knowledge exchanges across borders, and hospital-tier specific procurement strategies are all additional methods of facilitating the uptake and helping the region transition from early adopters to significant contributors to the refinement of devices and clinical practice. This maturing ecosystem will facilitate regional trials and localised technical refinements, as well as improve clinician confidence in using morcellation across a wide range of gynaecological care settings. Additionally, the increased regulatory engagement will support the ever-expanding use of morcellation in a wider variety of clinical environments.
Strong hospital infrastructure, surgical expertise and precision technology in Japan are driving morcellator use for surgery. Clinical evaluations and training for the use of laparoscopic power morcellators occur within academic and specialty surgical centers with a focus on collaboration with manufacturers to validate devices. In building confidence for surgical use of laparoscopic power morcellators, emphasis is placed on device reliability and safety of the procedure for achieving optimal outcomes. For the successful use and implementation of laparoscopic power morcellators in the minimally invasive gynecological care pathway, healthcare organizations emphasize integration of training and manufacturer service support.
The laparoscopic power morcellators industry in Korea has shown increased acceptance of use of the device by the surgical community with the support of surgical training program initiatives, specialty surgical centers and the involvement of global manufacturers of surgical devices. The interest by surgeons in using minimally invasive surgical approaches has created an opportunity for the continued development of reliable laparoscopic power morcellation platforms and the education of surgeons on using these platforms for surgical procedures through distribution networks that provide surgical education and technical support. The safety of the procedure, the assessment of surgical outcomes and the establishment of institutional credentialing are all key elements of helping normalise the use and increase the confidence of surgeons regarding the use of the device. Ongoing and collaborative research initiatives and specifically targeted training initiatives are also important elements for assisting with the integration of the devices of laparoscopic power morcellators into routine gynaecological practice hospital settings.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Technological Innovations In Devices
The recent progress made with morcellator designs have made morcellators safer and more efficient. Improved blade geometry, containment devices, and the integration of visualization technologies all contribute to mitigating intra-operative taboos thus allowing for a wider application of the device within the operating room, whilst also building confidence with surgeons and their teams; thereby promoting a better chance to have the morcellator used outside of the surgical suite. Further, the ergonomics and reliability of the new devices have enhanced the workflow, while reducing the time to complete a procedure; thus allowing for improved surgical staff training. Hospitals are giving attention to devices that impact the outcome of their surgical patients and increase operational efficiencies, therefore driving the decisions made with respect to purchasing the morcellator due to the clearer benefits seen in the clinical outcomes of these procedures; thereby increasing the demand from clinicians who are seeking newer minimally invasive devices.
Increasing Adoption Of Minimally Invasive Procedures
Safety Concerns Around Tissue Dissemination
Clinicians and institutions are reluctant to use or expand morcellator utilization due to the persistent fear of unintentional release of tissue during use. hospitals that have safety concerns require hospitals to create stricter procedural protocols as well as additional containment measures, and be limited in their indications for use, which complicates workflows and creates an increased burden on the clinician. Caution in using morcellators also plays a major role in procurement decisions and exploring alternatives to extracting tissue specimens. The market will remain constrained until the perception of improved safety due to improved reliability or consensus recommendations has provided confidence to clinicians and institutions.
Stringent Regulatory Oversight and Reimbursement Policies
Request Free Customization of this report to help us to meet your business objectives.
Competitive landscape is driven by regulatory pressure for contained extraction, forcing product launches, distribution partnerships, and portfolio consolidation. For example Olympus launched a contained power morcellator with Trokamed distribution. Minerva Surgical consolidated assets via acquisition of Boston Scientific intrauterine lines. Ark Surgical exemplifies containment innovation with FDA clearance for a dual wall LapBox.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global laparoscopic power morcellators market is poised for steady expansion as one key driver is the rising adoption of minimally invasive procedures that shorten recovery and improve throughput, while a second driver is ongoing technological innovations such as improved blade designs, containment systems and digital integration that enhance safety and workflow. One restraint is persistent safety concerns about tissue dissemination and resulting regulatory scrutiny that have slowed uptake and prompted containment-focused redesigns. North America remains the dominating region due to mature healthcare infrastructure and early adoption. Tissue Containment Systems are the dominating segment as hospitals prioritize risk mitigation and compliance to restore clinician confidence.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 108.9 Million |
| Market size value in 2033 | USD 196.87 Million |
| Growth Rate | 6.8% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Laparoscopic Power Morcellators Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Laparoscopic Power Morcellators Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Laparoscopic Power Morcellators Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Laparoscopic Power Morcellators Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Laparoscopic Power Morcellators Market size was valued at USD 108.9 Million in 2024 and is poised to grow from USD 116.31 Million in 2025 to USD 196.87 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).
Competitive landscape is driven by regulatory pressure for contained extraction, forcing product launches, distribution partnerships, and portfolio consolidation. For example Olympus launched a contained power morcellator with Trokamed distribution. Minerva Surgical consolidated assets via acquisition of Boston Scientific intrauterine lines. Ark Surgical exemplifies containment innovation with FDA clearance for a dual wall LapBox. 'Johnson & Johnson MedTech', 'Medtronic plc', 'Olympus Corporation', 'Richard Wolf GmbH', 'KARL STORZ SE & Co. KG', 'Conmed Corporation', 'B. Braun SE', 'Purple Surgical Holdings Limited', 'LiNA Medical ApS', 'Gyrus ACMI, Inc.', 'Hangzhou Kangji Medical Instrument Co., Ltd.', 'Xishan Medical Instruments Co., Ltd.', 'Changzhou Ankang Medical Instruments Co., Ltd.', 'WISAP Medical Technology GmbH', 'Ackermann Instrumente GmbH', 'Locamed Ltd.', 'Advin Health Care', 'Bluesail Surgical Co., Ltd.', 'Jinhua Yidi Medical Appliance Co., Ltd.', 'Tonglu WANHE Medical Instrument Co., Ltd.'
Advances in morcellator design, including improved blade geometry, better tissue containment systems, and integration with visualization technologies, enhance procedural safety and efficiency. These improvements reduce intraoperative challenges and increase surgeon confidence, facilitating broader adoption within surgical suites. Enhanced device ergonomics and reliability streamline workflow, decrease procedure time perceptions, and support training. As hospitals prioritize tools that improve patient outcomes and operational efficiency, clearer clinical benefits drive procurement decisions, stimulating demand among providers seeking modern minimally invasive solutions.
__Digital Integration And Connectivity__: Integration of morcellators with digital operating room ecosystems is accelerating adoption by enabling seamless connectivity with imaging, documentation, and inventory systems. Enhanced device telemetry and secure data exchange support remote monitoring, preventative maintenance, and performance benchmarking across provider networks. Interoperability with surgical platforms and training technologies promotes standardized workflows and faster clinician onboarding. Vendors focusing on software-enabled services and analytics create new value propositions around device uptime, procedure efficiency, and post-market support, shifting competition toward platform capabilities and service quality.
Why does North America Dominate the Global Laparoscopic Power Morcellators Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
